Brief: Vitrafy Life Sciences Announces Leadership Transition
Aug 5 (Reuters) - Vitrafy Life Sciences Ltd VFY.AX: LEADERSHIP TRANSITION AT VITRAFY KATE MUNNINGS WILL RETIRE AS MANAGING DIRECTOR & CEO KATE MUNNINGS TO REMAIN AS NON-EXECUTIVE DIRECTOR BRENT OWENS APPOINTED AS MANAGING DIRECTOR & CEO Further company coverage: VFY.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vitrafy Life Sciences
See all newsBrief: Vitrafy Life Sciences Appoints Jan Gielen As CFO
Australia's Vitrafy Life Sciences heads for best day in 2 months on Versiti deal
Australia's Vitrafy Life Sciences gains on entering US market
Brief: Vitrafy Life Sciences Enters U.S. Cell & Gene Therapy Market With Charter Medical Agreement
Brief: Vitrafy Life Sciences Posts FY Operating Loss Of A$14.6 Million